Delivery Order SPE2DB20D1100-SPE2DB24FA9Q5

Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $7,194.78 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 MCG inhaler 12GM. The contract has a completion date of February 26, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhaler 12 gm. The contract has a completion date of March 28, 2024 and a ceiling value of $1,293.26. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, that serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,987.86 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG Inhaler, 12 gm. This delivery order contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,042.55 for the supply of Advair HFA 230-21 mcg inhalers. The contract has a period of performance through March 1, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $17,942.06, is for the supply of Advair HFA 230-21 MCG inhalers to support military medical treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Advair HFA 115-21 MCG Inhaler 8GM. The contract has a ceiling value of $1,786.52 and an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG inhalers. The $3,729.54 contract has an ultimate completion date of April 8, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a potential value of $1,356.29 and a performance period ending on January 31, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order contract is...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of an Advair HFA 115-21 mcg inhaler product. The contract, valued at $3,822.15, has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations noted. This delivery order is part of a larger indefinite delivery contract (IDC) with a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA9Q5
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The contract has a ceiling value of $4,600.20 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for these contracts.

Generated 6/25/24, 1:14 PM